NanoEntek, Inc. (KOSDAQ:039860)
South Korea · Delayed Price · Currency is KRW 3,125.00
-100.00 (-3.10%)
At close: Oct 30, 2025
NanoEntek Company Description
NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally.
It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a residual white blood cell counters; ADAMII/fluorescence stem cell counter; fluorescence cell counters and cell analyzers; brightfield cell counters; somatic cell counters; live-cell imaging system; and disposable hemocytometers.
The company was founded in 1987 and is headquartered in Seoul, South Korea.
NanoEntek, Inc.
| Country | South Korea |
| Founded | 1987 |
| Industry | Laboratory Analytical Instruments |
| Employees | 97 |
| CEO | Jin-Hyung Park |
Contact Details
Address: 5, Digital-ro 26-gil Seoul, 08389 South Korea | |
| Phone | 82 2 6220 7728 |
| Website | nanoentek.com |
Stock Details
| Ticker Symbol | 039860 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Jin-Hyung Park | Chief Executive Officer |